Omega-3
Best for
Raise omega-3 levels
Likely strong benefit for 0–244 weeks · 1 meta-analysis , n=3k
202 papers · 16 claims · 322 outcomes scored · 14 positive
Outcomes
What omega-3 actually does, by outcome
Each row is one outcome with effect size, evidence base, the dose that worked in trials, and time to first effect. Magnitude tiers come from native-unit MCID where available, Cohen's d otherwise.
EPA and DHA build up in blood and cell membranes where they work.
Tops up the reserves pregnancy drains fastest.
Body fat percentage drops and the mirror shows it before the scale does.
Slows retinal damage to preserve the central vision you use most.
Builds the protective pigment that shields your central vision from age.
Builds a steadier tear film so your eyes stay comfortable between blinks.
Better reading scores, sharper math, and fewer absences.
Reduces the blood fats that rise after meals and drive heart risk.
Keeps sight sharper and retinal signals healthier when disease threatens.
Memory, attention, and orientation hold up longer before fading.
Less raw material for inflammation, more for resolving it.
Broad gains in memory, speed, and mental sharpness at once.
Babies who arrive at the right size face fewer risks at birth.
Names, conversations, faces, and details stick instead of dissolving.
Pick out finer detail, edges, and text more easily.
| Outcome | Effect | Evidence | Dose | Weeks | Rank |
|---|---|---|---|---|---|
| Raise omega-3 levels Likely strong benefit | | 35 meta-analyses n=3.0k Meta-analyzed | 2.5–9120 mg | 0–244 wk | #1/6 |
| Build nutrient stores in pregnancy Likely strong benefit | | 1 RCT n=238 | 200–1000 mg | — | #2/4 |
| Lose body fat Large effect, needs confirmation | | 5 RCTs n=136 | 3–3900 mg | 8–26 wk | #8/56 |
| Slow macular degeneration progression Likely strong benefit | | 2 meta-analyses n=— Meta-analyzed | 1000 mg | 260 wk | #2/5 |
| Protect against macular degeneration Large effect, needs confirmation | | 2 meta-analyses n=— Meta-analyzed | 1000 mg | 260 wk | #1/6 |
| Ease dry, gritty eyes Likely benefit | | 6 meta-analyses n=6.4k Meta-analyzed | 300–3000 mg | 8–52 wk | #1/3 |
| Improve school results in children Likely benefit | | 2 RCTs n=362 | 600–800 mg | 16 wk | — |
| Lower triglycerides Proven modest benefit | | 32 meta-analyses n=116k Meta-analyzed | 0.3–14000 g | 3–183 wk | #1/89 |
| Protect vision in retinal disease Faint early signal | | 3 meta-analyses n=5.6k Meta-analyzed | 600–3600 mg | 208 wk | #5/5 |
| Slow cognitive decline in dementia Proven modest benefit | | 6 meta-analyses n=2.7k Meta-analyzed | 480–3000 mg | 17–156 wk | #3/23 |
| Improve omega-3 to omega-6 ratio Likely modest benefit | | 14 meta-analyses n=1.1k Meta-analyzed | 2.5–9120 mg | 3–56 wk | #1/6 |
| Boost overall cognitive performance Barely detectable | | 7 meta-analyses n=14k Meta-analyzed | 230–4950 mg | 26–260 wk | #5/21 |
| Strengthen healthy birth weight Proven but unnoticeable | | 2 meta-analyses n=8.7k Meta-analyzed | 200–1000 mg | — | #6/7 |
| Strengthen your memory Proven but unnoticeable | | 11 meta-analyses n=1.5k Meta-analyzed | 37–4950 mg | 16–156 wk | #6/42 |
| Sharpen visual clarity Not enough research | | 2 meta-analyses n=5.5k Meta-analyzed | — | — | — |
| Build thinking skills in children Doesn't appear to help | | 3 meta-analyses n=5.5k Meta-analyzed | 800 mg | — | — |
Recommended Omega-3 products
Real products that dose Omega-3 where the research does, in a clean formulation, from brands we've audited. We only list ones we'd stand behind.
-
Nootropics Depot
70% DHA Fish Oil Softgels 1,000 mg
Well dosed 650 mg/day A formulaBrand audit 87/100
-
Nature Made
Omega-3 with Xtra Absorb Technology
Well dosed 576 mg/day A formulaBrand audit 80/100
-
Thorne
Super EPA 425 mg
Well dosed 2,439 mg/day A formulaBrand audit 79/100
-
Thorne
Prenatal DHA 650 mg
Well dosed 960 mg/day A formulaBrand audit 79/100
-
Pure Encapsulations
UltraKrill+D
Well dosed 1,400 mg/day A formulaBrand audit 78/100
-
Nature's Answer
Liquid Omega-3 Natural Orange Flavor
Well dosed 1,150 mg/day A formulaBrand audit 75/100
Chosen for adequate Omega-3 dosing vs. the studied range, a clean formulation (grade A–C), and independent brand-quality audits. Not sponsored.
Risk profile
Adverse events and known drug interactions
Safety events
Drug interactions
Co-studied with
Supplements that share evidence with omega-3
-
Omega6Fattyacids Group 8 shared outcomes · d=0.36 - Arachidonicacid 4 shared outcomes · d=1.84
Sources
- 1. Supplementation-induced increase in circulating omega-3 serum levels is not associated with a reduction in depressive symptoms: Results from the MooDFOOD depression prevention trial. (2020) ↑
- 2. Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled study. (2009) ↑
- 3. A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder. (2009) ↑
- 4. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. (2010) ↑
- 5. Incorporation of n-3 PUFA and γ-linolenic acid in blood lipids and red blood cell lipids together with their influence on disease activity in patients with chronic inflammatory arthritis--a randomized controlled human intervention trial. (2011) ↑
- 6. Omega-3 fatty acids, oxidative stress, and leukocyte telomere length: A randomized controlled trial. (2013) ↑
- 7. Docosahexaenoic acid supplementation, vascular function and risk factors for cardiovascular disease: a randomized controlled trial in young adults. (2013) ↑
- 8. A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease. (2014) ↑
- 9. Reduced Symptoms of Inattention after Dietary Omega-3 Fatty Acid Supplementation in Boys with and without Attention Deficit/Hyperactivity Disorder. (2015) ↑
- 10. No Effect of Omega-3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer's Disease: A Randomised Controlled Trial. (2015) ↑
Generated August 14, 2026
Related
More evidence for Omega-3
Ranking
Attention-Deficit/Hyperactivity Disorder
NewBest Supplements to Ease ADHD Symptoms in Children (2026)
Evidence ranking
May 17, 2026
Ranking
Arthritis and joint pain
NewBest Supplements for Arthritis and Joint Pain, Ranked by Clinical Evidence
Evidence ranking
Apr 4, 2026
Ranking
Depression
NewBest Supplements for Depression, Ranked by Clinical Evidence
Evidence ranking
Apr 4, 2026
Ranking
Migraines and Headaches
NewBest Supplements for Migraines and Headaches, Ranked by Clinical Evidence
Evidence ranking
Apr 4, 2026
Ranking
Brain fog and mental clarity
NewBest Supplements for Brain Fog and Mental Clarity, Ranked by Evidence
Evidence ranking
Apr 4, 2026
Ranking
Staying asleep through the night
NewBest Supplements to Stay Asleep Through the Night
Evidence ranking
Apr 4, 2026